CVE:EBN Epicore BioNetworks (EBN) Stock Price, News & Analysis C$1.29 -0.01 (-0.77%) (As of 12/14/2017) Add Compare Share Share Today's RangeC$1.29▼C$1.2950-Day RangeC$1.29▼C$1.2952-Week RangeC$0.54▼C$1.32Volume54,778 shsAverage Volume29,654 shsMarket CapitalizationC$34.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Epicore BioNetworks alerts: Email Address Ad Mode MobilePre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.Claim Exclusive 100% Bonus: $0.25/Share About Epicore BioNetworksEpicore BioNetworks Inc. (Epicore) develops, manufactures and markets specialty biotechnology, biochemical and nutrition products. Epicore specialty biochemical products are mixtures of specialty organic, inorganic and biochemical ingredients that facilitate microbe and plant growth. Some Epicore products (such as its EPIZYM-AGP COMPLETE) stimulate algae growth, an important property in shrimp and bivalve hatcheries that grow algae as animal food. Some of its products (such as EPIZYM-BGM) support microbe growth for customers who grow-up an Epicore microbial ecosystem at their location. Some Epicore biochemical products stimulate plant growth to increase plant yield and environmental stress resistance. The third Epicore product group is specialty animal feeds. These products are an extension of its microbial growth media expertise and are primarily used in aquaculture. Its EPIFEED -LHF and EPILITE liquid shrimp larval feeds are tools to help hatchery managers raise postlarval shrimp.Read More EBN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EBN Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive EBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Epicore BioNetworks and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolCVE:EBN CUSIPN/A CIKN/A Webepicorebionetworks.com Phone+1-609-2679118FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares26,380,000Free FloatN/AMarket CapC$34.03 million OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesWilliam P. LongPresident, Chief Executive Officer, Chief Operating Officer, DirectorRussell RosenzweigChief Financial Officer, Company SecretaryRobert Stephen PoultonNon-Executive Chairman of the BoardDonald R. SiemensDirectorStefan Zaphiriou ZarifiDirectorAlan C. SavageIndependent DirectorMore ExecutivesKey CompetitorsRMP EnergyTSE:RMPBrightPath Early LearningCVE:BPE812575 (SGF.TO)TSE:SGF53693 (VGO.V)CVE:VGO231872 (SCC.TO)TSE:SCCView All Competitors EBN Stock Analysis - Frequently Asked Questions How have EBN shares performed this year? Epicore BioNetworks' stock was trading at C$1.29 at the beginning of the year. Since then, EBN shares have increased by 0.0% and is now trading at C$1.29. View the best growth stocks for 2024 here. How do I buy shares of Epicore BioNetworks? Shares of EBN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Epicore BioNetworks own? Based on aggregate information from My MarketBeat watchlists, some other companies that Epicore BioNetworks investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR) and Advanced Emissions Solutions (ADES). This page (CVE:EBN) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Epicore BioNetworks Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Epicore BioNetworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.